Introduction: Logically valid deductive arguments are clear examples of abstract recursive computational procedures on propositions or on probabilities. However, it is not known if the cortical time-consuming inferential processes in which logical arguments are eventually realized in the brain are in fact physically different from other kinds of inferential processes.
Methods: In order to determine whether an electrical EEG discernible pattern of logical deduction exists or not, a new experimental paradigm is proposed contrasting logically valid and invalid inferences with exactly the same content (same premises and same relational variables) and distinct logical complexity (propositional truth-functional operators). Electroencephalographic signals from 19 subjects (24.2 ± 3.3 years) were acquired in a two-condition paradigm (100 trials for each condition). After the initial general analysis, a trial-by-trial approach in beta-2 band allowed to uncover not only evoked but also phase asynchronous activity between trials.
Results: showed that (i) deductive inferences with the same content evoked the same response pattern in logically valid and invalid conditions, (ii) mean response time in logically valid inferences is 61.54% higher, (iii) logically valid inferences are subjected to an early (400 ms) and a late reprocessing (600 ms) verified by two distinct beta-2 activations (p-value < 0,01, Wilcoxon signed rank test).
Conclusion: We found evidence of a subtle but measurable electrical trait of logical validity. Results put forward the hypothesis that some logically valid deductions are recursive or computational cortical events.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247637 | PMC |
http://dx.doi.org/10.1186/s40708-023-00194-8 | DOI Listing |
Background: Two main risk factors of Alzheimer's disease (AD) are aging and APOE-ε4. However, some individuals remain cognitively normal despite having these risk factors. They are considered "cognitively resilient".
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Department of Anatomy & Neurobiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Background: Preclinical measures of Alzheimer's disease (AD) risk include markers of amyloid and tau measured via PET scans and decline in verbal memory. Audio features from recorded speech collected during neuropsychological testing offer an alternative for monitoring preclinical AD symptoms that is nonintrusive, economical, and scalable but warrants further validation. This study aims to examine whether there is a stronger association between acoustic metrics and PET imaging biomarkers compared to a traditional verbal memory test.
View Article and Find Full Text PDFBackground: Alzheimer's disease (AD) patients have decline in cognitive domains including memory, language, visuospatial, and/or executive function and brain pathology including amyloid-β and tau deposition, neurodegeneration, and frequent vascular co-pathologies detectable by neuroimaging and/or cerebrospinal fluid biomarkers. However, molecular disease mechanisms are complex and heterogeneous. It is necessary to develop cost-effective blood-based biomarkers reflecting brain molecular perturbations in AD.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Background: Dementia poses a significant global crisis, yet 60% of cases go undetected, particularly among specific sub-populations. Timely diagnosis is crucial for implementing early intervention strategies. Challenges of current screening tools (e.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Consortium pour l'Identification précoce de la Maladie d'Alzheimer - Québec, Montréal/Québec/Sherbrooke, QC, Canada.
Background: Olfactory identification is impaired in the early stages of Alzheimer's disease (AD), including mild cognitive impairment (MCI). This early sensory impairment could result from several factors such as early cognitive or structural cerebral damages caused by the disease. It is however not clear which factors are contributing the most to the olfactory impairment in older people at risk of developing AD.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!